RxDoctor Payments Data

Margaret Joyce

Physician Assistant · Towson, MDNPI 1588796239

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $191,732 of the $219,903 with a category attached, or 87.2%. AbbVie accounts for 88.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $66,844 and has fallen 71.7% since, to $18,921 in 2025. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$219,903in general payments, 2019–2025

Across 450 payments — averaging $488.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$195K
  • Galderma Laboratories, L.p.$25K
  • Johnson & Johnson$137

What the payments were for

  • Consulting fees$4,3962%
  • Speaking & faculty fees$191,73287%
  • Travel & lodging$15,5397%
  • Food & beverage$8,2364%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)393$194,609
Galderma Laboratories, L.p.54$25,158
Johnson & Johnson3$137

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$219,903 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Other physician assistant in Towson

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →